Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)
China
· Delayed Price · Currency is CNY 27.02
+0.75 (2.85%)
Jun 3, 2025, 2:45 PM CST
SHA:605369 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Operating Revenue | 1,093 | 1,100 | 955.61 | 1,459 | 1,188 | 819.51 | Upgrade
|
| Other Revenue | 15.02 | 15.02 | 19.47 | 9.25 | 5.85 | 10.14 | Upgrade
|
| Revenue | 1,108 | 1,115 | 975.08 | 1,469 | 1,194 | 829.65 | Upgrade
|
| Revenue Growth (YoY) | 8.52% | 14.37% | -33.61% | 22.98% | 43.95% | 50.03% | Upgrade
|
| Cost of Revenue | 749.06 | 752.09 | 661.42 | 894.14 | 668.83 | 439.12 | Upgrade
|
| Gross Profit | 358.71 | 363.12 | 313.66 | 574.54 | 525.42 | 390.53 | Upgrade
|
| Selling, General & Admin | 141.78 | 141.21 | 148.2 | 162.48 | 120.43 | 74.88 | Upgrade
|
| Research & Development | 52.54 | 53.05 | 47.81 | 72.35 | 58.29 | 36.98 | Upgrade
|
| Other Operating Expenses | 11 | 10.17 | 8.51 | 12.89 | 7.71 | 6.15 | Upgrade
|
| Operating Expenses | 209.63 | 208.95 | 204.17 | 250.32 | 189.4 | 121.04 | Upgrade
|
| Operating Income | 149.07 | 154.18 | 109.49 | 324.22 | 336.02 | 269.49 | Upgrade
|
| Interest Expense | -4.45 | -2.87 | -1.45 | -0.04 | -0.03 | - | Upgrade
|
| Interest & Investment Income | 22.95 | 30.99 | 17.67 | 15.01 | 20.63 | 4.22 | Upgrade
|
| Currency Exchange Gain (Loss) | 5.97 | 5.97 | -5.39 | 29.65 | -5.45 | -13.64 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.48 | -0.28 | -0.23 | -0.41 | -1.53 | -0.27 | Upgrade
|
| EBT Excluding Unusual Items | 172.07 | 187.98 | 120.09 | 368.43 | 349.64 | 259.8 | Upgrade
|
| Impairment of Goodwill | -1.24 | -1.24 | -0.91 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.33 | 4.07 | - | -1.83 | - | 0.35 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.18 | -0.02 | -0.01 | -0.1 | 9.19 | -1.01 | Upgrade
|
| Asset Writedown | -0.66 | - | -1.69 | -1.48 | -2.29 | - | Upgrade
|
| Other Unusual Items | -2.06 | -2.06 | 1.74 | 5.66 | 4.2 | 3.28 | Upgrade
|
| Pretax Income | 163.61 | 188.74 | 119.23 | 370.67 | 360.73 | 262.42 | Upgrade
|
| Income Tax Expense | 9.95 | 17.23 | 10.1 | 44.63 | 49.74 | 36.54 | Upgrade
|
| Earnings From Continuing Operations | 153.66 | 171.5 | 109.13 | 326.04 | 310.99 | 225.88 | Upgrade
|
| Minority Interest in Earnings | 0.28 | 0.13 | - | - | - | - | Upgrade
|
| Net Income | 153.94 | 171.63 | 109.13 | 326.04 | 310.99 | 225.88 | Upgrade
|
| Net Income to Common | 153.94 | 171.63 | 109.13 | 326.04 | 310.99 | 225.88 | Upgrade
|
| Net Income Growth | 22.83% | 57.28% | -66.53% | 4.84% | 37.68% | 98.86% | Upgrade
|
| Shares Outstanding (Basic) | 159 | 157 | 158 | 157 | 157 | 127 | Upgrade
|
| Shares Outstanding (Diluted) | 159 | 157 | 158 | 157 | 157 | 127 | Upgrade
|
| Shares Change (YoY) | 0.49% | -0.44% | 0.83% | -0.20% | 23.76% | 7.81% | Upgrade
|
| EPS (Basic) | 0.97 | 1.09 | 0.69 | 2.08 | 1.98 | 1.78 | Upgrade
|
| EPS (Diluted) | 0.97 | 1.09 | 0.69 | 2.08 | 1.98 | 1.78 | Upgrade
|
| EPS Growth | 22.24% | 57.97% | -66.81% | 5.05% | 11.24% | 84.45% | Upgrade
|
| Free Cash Flow | 58.28 | 100.77 | 63.57 | 110.57 | 97.43 | 133.61 | Upgrade
|
| Free Cash Flow Per Share | 0.37 | 0.64 | 0.40 | 0.70 | 0.62 | 1.05 | Upgrade
|
| Dividend Per Share | 0.700 | 0.700 | 0.571 | 0.214 | 0.986 | 0.918 | Upgrade
|
| Dividend Growth | 22.51% | 22.51% | 166.64% | -78.26% | 7.33% | - | Upgrade
|
| Gross Margin | 32.38% | 32.56% | 32.17% | 39.12% | 44.00% | 47.07% | Upgrade
|
| Operating Margin | 13.46% | 13.83% | 11.23% | 22.07% | 28.14% | 32.48% | Upgrade
|
| Profit Margin | 13.90% | 15.39% | 11.19% | 22.20% | 26.04% | 27.23% | Upgrade
|
| Free Cash Flow Margin | 5.26% | 9.04% | 6.52% | 7.53% | 8.16% | 16.10% | Upgrade
|
| EBITDA | 230.98 | 236.5 | 193.48 | 364.88 | 357.54 | 288.4 | Upgrade
|
| EBITDA Margin | 20.85% | 21.21% | 19.84% | 24.84% | 29.94% | 34.76% | Upgrade
|
| D&A For EBITDA | 81.9 | 82.32 | 83.99 | 40.66 | 21.52 | 18.91 | Upgrade
|
| EBIT | 149.07 | 154.18 | 109.49 | 324.22 | 336.02 | 269.49 | Upgrade
|
| EBIT Margin | 13.46% | 13.83% | 11.23% | 22.07% | 28.14% | 32.48% | Upgrade
|
| Effective Tax Rate | 6.08% | 9.13% | 8.47% | 12.04% | 13.79% | 13.92% | Upgrade
|
| Revenue as Reported | 1,108 | 1,115 | 975.08 | 1,469 | 1,194 | 829.65 | Upgrade
|
| Advertising Expenses | - | 4.36 | 4.17 | 3.56 | 24.14 | 13.83 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.